{"title":"抗精神病药物对肠道微生物群的影响有何意义?","authors":"Mary V Seeman","doi":"10.1080/17425255.2023.2200161","DOIUrl":null,"url":null,"abstract":"A healthy balance among the many life forms that inhabit the human gut is vital not only to our gastrointestinal system but also to all our important physiological systems – the central and autonomic nervous system, the immune system, and the endocrine system. These disparate networks influence each other in multiple reciprocal ways. This commentary focuses on one specific aspect of these interconnections – how a class of therapeutic drugs, the antipsychotics (AP), affects the gut microbiome, and how that effect, in turn, influences AP efficacy and tolerability. AP drugs are the gold standard treatment for schizophrenia and are prescribed for all psychotic disorders (delusional disorder, depression, or mania with psychotic features, schizoaffective disorder, metabolic, or neurologic or toxic disorders that result in psychotic symptoms, such as delusions and hallucinations). Sometimes, at relatively low doses, AP are also prescribed for more everyday conditions, such as insomnia, severe anxiety, emotional trauma, eating disorders, or aggression. The gut microbiome is significantly impacted by these drugs, especially when they are taken orally. This is because many of the main indications for AP treatment require lifelong and relatively high daily drug doses. AP influence in the gut can, therefore, be substantial, prolonged, and cumulative [1]. While these influences pertain to treatment via the mouth and gastrointestinal system, AP does not need to be given orally. They can be administered through other routes, one of the most effective being monthly intramuscular injections that avoid first-pass metabolism through the liver and leave gut microbiota comparatively unchanged. Giving pills by mouth is the current clinical routine, although it has become evident that nurse-administered injections at regular time intervals are safe and effective. Such administration overcomes the problems of forgetfulness, deliberate non-adherence, and intentional overdose. Long-acting injections have been shown to result in better outcomes than orally taken drugs [2].","PeriodicalId":12250,"journal":{"name":"Expert Opinion on Drug Metabolism & Toxicology","volume":"19 3","pages":"125-127"},"PeriodicalIF":3.9000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What is the significance of the impact of antipsychotics on the gut microbiome?\",\"authors\":\"Mary V Seeman\",\"doi\":\"10.1080/17425255.2023.2200161\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A healthy balance among the many life forms that inhabit the human gut is vital not only to our gastrointestinal system but also to all our important physiological systems – the central and autonomic nervous system, the immune system, and the endocrine system. These disparate networks influence each other in multiple reciprocal ways. This commentary focuses on one specific aspect of these interconnections – how a class of therapeutic drugs, the antipsychotics (AP), affects the gut microbiome, and how that effect, in turn, influences AP efficacy and tolerability. AP drugs are the gold standard treatment for schizophrenia and are prescribed for all psychotic disorders (delusional disorder, depression, or mania with psychotic features, schizoaffective disorder, metabolic, or neurologic or toxic disorders that result in psychotic symptoms, such as delusions and hallucinations). Sometimes, at relatively low doses, AP are also prescribed for more everyday conditions, such as insomnia, severe anxiety, emotional trauma, eating disorders, or aggression. The gut microbiome is significantly impacted by these drugs, especially when they are taken orally. This is because many of the main indications for AP treatment require lifelong and relatively high daily drug doses. AP influence in the gut can, therefore, be substantial, prolonged, and cumulative [1]. While these influences pertain to treatment via the mouth and gastrointestinal system, AP does not need to be given orally. They can be administered through other routes, one of the most effective being monthly intramuscular injections that avoid first-pass metabolism through the liver and leave gut microbiota comparatively unchanged. Giving pills by mouth is the current clinical routine, although it has become evident that nurse-administered injections at regular time intervals are safe and effective. Such administration overcomes the problems of forgetfulness, deliberate non-adherence, and intentional overdose. Long-acting injections have been shown to result in better outcomes than orally taken drugs [2].\",\"PeriodicalId\":12250,\"journal\":{\"name\":\"Expert Opinion on Drug Metabolism & Toxicology\",\"volume\":\"19 3\",\"pages\":\"125-127\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Opinion on Drug Metabolism & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17425255.2023.2200161\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Drug Metabolism & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17425255.2023.2200161","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
What is the significance of the impact of antipsychotics on the gut microbiome?
A healthy balance among the many life forms that inhabit the human gut is vital not only to our gastrointestinal system but also to all our important physiological systems – the central and autonomic nervous system, the immune system, and the endocrine system. These disparate networks influence each other in multiple reciprocal ways. This commentary focuses on one specific aspect of these interconnections – how a class of therapeutic drugs, the antipsychotics (AP), affects the gut microbiome, and how that effect, in turn, influences AP efficacy and tolerability. AP drugs are the gold standard treatment for schizophrenia and are prescribed for all psychotic disorders (delusional disorder, depression, or mania with psychotic features, schizoaffective disorder, metabolic, or neurologic or toxic disorders that result in psychotic symptoms, such as delusions and hallucinations). Sometimes, at relatively low doses, AP are also prescribed for more everyday conditions, such as insomnia, severe anxiety, emotional trauma, eating disorders, or aggression. The gut microbiome is significantly impacted by these drugs, especially when they are taken orally. This is because many of the main indications for AP treatment require lifelong and relatively high daily drug doses. AP influence in the gut can, therefore, be substantial, prolonged, and cumulative [1]. While these influences pertain to treatment via the mouth and gastrointestinal system, AP does not need to be given orally. They can be administered through other routes, one of the most effective being monthly intramuscular injections that avoid first-pass metabolism through the liver and leave gut microbiota comparatively unchanged. Giving pills by mouth is the current clinical routine, although it has become evident that nurse-administered injections at regular time intervals are safe and effective. Such administration overcomes the problems of forgetfulness, deliberate non-adherence, and intentional overdose. Long-acting injections have been shown to result in better outcomes than orally taken drugs [2].
期刊介绍:
Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
The Editors welcome:
Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.
Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.
The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.